Last reviewed · How we verify
NCT06820125
Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation
NA trial testing Cognitive rehabilitation: CG group in Rehabilitation in 48 participants. Currently enrolling.
5 July 2023
Quick facts
| Lead sponsor | Universita di Verona |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 5 July 2023 |
| Primary completion | 5 July 2023 |
| Estimated completion | 5 July 2026 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Cognitive rehabilitation: CG group
- Motor rehabilitation: MG group
- Combined rehabilitation: CbG group
Conditions studied
- Rehabilitation — all drugs for Rehabilitation →
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
- Cognitive Deficit — all drugs for Cognitive Deficit →
- Motor Deficits — all drugs for Motor Deficits →
Sponsor
Universita di Verona — full company profile →
Who can join
18 and older, any sex, with Rehabilitation or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The first aim of this project is to investigate the effects of different high-tech neurorehabilitation interventions (cognitive, motor, and combined cognitive-motor) on both cognitive and motor disability outcomes in people with multiple sclerosis (MS). The second aim is to identify the cognitive and motor profiles of MS patients who benefit the most from either the combined cognitive-motor rehabilitation intervention or the isolated cognitive or motor treatments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06820125
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rehabilitation
Currently open trials in the same condition.
- NCT07450274 — Rehabilitation of Upper Limbs After Stroke · NA · recruiting
- NCT07419217 — Professional Impact of Osteoarticular Trauma · recruiting
- NCT07399262 — Music-Augmented Rhythmic Gait Training in Multiple Sclerosis · NA · recruiting
- NCT07333079 — Rehabilitation With Biofeedback for People After Stroke · NA · recruiting
- NCT07304180 — Exergame vs Balance Training in Hemiplegia · NA · active not recruiting
Other Universita di Verona trials
Trials by the same sponsor.
- NCT07393919 — Discontination of Antidepressants in Remitted Depression · Phase 4 · not yet recruiting
- NCT07042724 — Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study · NA · recruiting
- NCT07129954 — Fear of Falling in Muscular Dystrophy · NA · recruiting
- NCT07119827 — Personality Traits as a Variable in the Recovery of Patients With Acquired Brain Injury · recruiting
- NCT07209306 — WHO Psychological Interventions for Mental Health Outcomes in Migrants Resettled in Italy: the ADVANCE Trial · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06820125 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universita di Verona
- Last refreshed: 11 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06820125.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing